Compare DRDB & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRDB | VOR |
|---|---|---|
| Founded | 2024 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.8M | 345.1M |
| IPO Year | 2024 | 2021 |
| Metric | DRDB | VOR |
|---|---|---|
| Price | $10.49 | $12.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $64.78 |
| AVG Volume (30 Days) | 40.4K | ★ 1.1M |
| Earning Date | 01-01-0001 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $600.98 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.87 | $2.62 |
| 52 Week High | $10.55 | $65.80 |
| Indicator | DRDB | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 52.82 | 44.15 |
| Support Level | $10.48 | $13.00 |
| Resistance Level | $10.52 | $15.00 |
| Average True Range (ATR) | 0.03 | 1.50 |
| MACD | 0.00 | -0.40 |
| Stochastic Oscillator | 50.00 | 9.55 |
Roman DBDR Acquisition Corp II is a blank check company.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.